Evaluation of the safety and effectiveness of prostate‐specific antigen (PSA) monitoring in primary care after discharge from hospital‐based follow‐up following prostate cancer treatment-Reference-Cited by-同舟云学术

Evaluation of the safety and effectiveness of prostate‐specific antigen (PSA) monitoring in primary care after discharge from hospital‐based follow‐up following prostate cancer treatment

Published:2020-12-18 Issue:4 Volume:30 Page:
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Johnson Helen¹^ORCID,Taylor Sally²^ORCID,Peat Sara²,Booker Jane¹,Yorke Janelle²³^ORCID

Affiliation:

1. The Christie NHS Foundation Trust Manchester UK

2. The Christie Patient Centred Research Team The Christie School of Oncology The Christie NHS Foundation Trust Manchester UK

3. Division of Nursing, Midwifery and Social Work School of Health Sciences University of Manchester Manchester UK

Funder

Urology Foundation

Publisher

Wiley

Subject

Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ecc.13389

Reference33 articles.

1. "To be followed up in general practice" - developing and implementing a shared care model for prostate cancer.

2. Development of a PSA tracking system for patients wtih prostate cancer following definitive radiotherapy to enhance rural health.

3. ProCare Trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of aggregation‐induced emission materials in urinary system diseases;Aggregate;2024-05-10

2. The Influence of Tumor-Specific Markers in Breast Cancer on Other Blood Parameters;Life;2024-03-29

3. Changes of Tumor Markers in Patients with Breast Cancer during Postoperative Adjuvant Chemotherapy;Disease Markers;2022-05-19